The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

Recent research suggests that type 2 diabetes may increase the risk for some cancers typically related to obesity. Image credit: Nata Segueza/Stocksy. For this study, researchers analyzed data from ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

People with type 2 diabetes usually have a higher risk of pancreatic cancer compared with people without type 2 diabetes. But that risk may depend on how long you’ve had type 2 diabetes. People who ...

March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...

If you have type 2 diabetes, it’s important to manage your hormone levels, as an imbalance can alter how your body responds to insulin. Lifestyle measures like reducing stressors and eating a balanced ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

Around 1.2 million Australians live with type 2 diabetes, yet there is no government subsidy for CGMs, despite this being well-established ...

More than 38 million Americans have diabetes and of them, up to 95% have type 2 diabetes, according to the Centers for Disease Control and Prevention (CDC). While the condition usually develops in ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.